Introduction Systemic Capillary Leak Syndrome (SCLS) is a rare disease characterized by recurrent life-threatening attacks of capillary hyper permeability in the presence of a monoclonal gammopathy (MG).
Introduction Systemic Capillary Leak Syndrome (SLCS) is a rare disease characterized by recurrent life-threatening attacks of capillary hyper permeability in the presence of a monoclonal gammopathy (MG).
For these measures, the following were considered as indicating a disability: the existence of recurrent life-threatening anaphylactoid episodes, ≥7 episodes of flushing per week, ≥4 stools per day (diarrhea), ≥8 micturitions per day (pollakiuria), pruritus score ≥6, Hamilton score ≥10 (depression), QLQ-C30 score ≥60.
Patients were considered to have a disability when they had recurrent life-threatening anaphylactoid episodes (19%), ≥7 episodes of flushing per week (66%), ≥4 stools per day (12%), ≥8 micturitions per day (32%), a pruritus score ≥6 (77%), a Hamilton rating score ≥10 (75%), or a QLQ-C30 score ≥60 (32%) (Table 7).
This leads to recurrent life-threatening bacterial and fungal infections with tissue granuloma formation.
Recurrent life-threatening variceal haemorrhage secondary to portal hypertension is an indication for liver transplantation.
After assessment in a supraregional transplant unit, ITx was recommended on the basis of recurrent life-threatening sepsis.
This leads to recurrent life-threatening bacterial and fungal infections as well as persistent tissue granuloma formation.
We report two children with recurrent life-threatening CRBSI who were removed from the ITx list when foster care placement led to virtual cessation of septic episodes.
Two children died within 60 h after birth; the other two had recurrent life-threatening metabolic crises but were successfully managed with supplementation of anaplerotic amino acids, lipids, and symptomatic treatment during metabolic crisis.
